Expected Moves

Estimated Q3 2026 Earnings Release focusing on order-book survival. Starting from a $0.00 base price, the favorable path models a massive squeeze to a $0.15 target if a backlog surprise materializes, while the adverse path risks total wipeout at a $0.00 fallback.

Potential update on restructuring or asset liquidation. From a $0.00 base price, the adverse baseline is continued impairment at a $0.00 fallback, while a distressed buyout could theoretically yield a $0.10 target.

Estimated release of FY 2026 results. Anchored at a $0.00 base price, a $0.08 target relies on a miraculous backlog pivot, while a $0.00 fallback remains the terminal state.